Ischaemic left ventricular dysfunction: a preventable precursor of heart failure?
Waller
D G
DG
Medicine and Clinical Pharmacology, Southampton General Hospital, UK.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002303:Cardiac Output, Low / Q000209:etiology / Q000517:prevention & control*; D003326:Coronary Circulation; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000150:complications; D017202:Myocardial Ischemia / Q000150:complications* / Q000188:drug therapy*; D009204:Myocardial Revascularization; D015221:Potassium Channels / Q000819:agonists*; D018487:Ventricular Dysfunction, Left / Q000150:complications* / Q000209:etiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D015221:Potassium Channels